Abstract
In the present work, we report that the functional serotonin transporter gene promoter (5–HTTLPR) polymorphism is involved in migraine pathogenesis. The distribution of 5–HTTLPR genotypes was significantly different in MA patients (S/S vs. S/L vs. L/L=32.7 vs. 42.3 vs. 25.0%), MO patients (18.5 vs. 39.1 vs. 42.4%) and CON (18.0 vs. 51.3 vs. 30.7%; chi–square test, p<0.05). In 5–HTTLPR S/S carriers, the odds ratio for MA risk was 2.60 (95% confidence interval [95%CI]=1.75–3.85) compared to CON, and it was 2.14 (95%CI=1.42–3.21) compared to MO. These data provide a further insight on the complex genotypephenotype relationship involved in MA pathogenesis, and might eventually result in new and individualised prognostic and therapeutic measures.
Article PDF
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License ( https://creativecommons.org/licenses/by-nc/2.0 ), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
About this article
Cite this article
Borroni, B., Brambilla, C., Liberini, P. et al. Functional serotonin 5–HTTLPR polymorphism is a risk factor for migraine with aura. J Headache Pain 6, 182–184 (2005). https://doi.org/10.1007/s10194-005-0179-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10194-005-0179-9